Back to mobile site

Repros Therapeutics, Inc. (RPRX) Tops Q4 EPS by 6c

March 27, 2012 9:27 AM EDT
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q4 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $1 thousand.

For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings